Exchange: NASDAQ·Updated 01:48 PM EDT
HUMA logo

HUMA Humacyte Inc

$0.5981
$0.0021
(0.35%)
Today
Reported EarningsAug 12
Mkt Cap$165.57M
Vol1.31M

About HUMA

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
39

Bearish Sentiment

How do you feel about HUMA?

Advertisement|Remove ads.